Abstract
A range of isatin-thiazolidinone hybrid analogues were synthesized and their cytotoxicity was evaluated against several cancer cell lines in vitro. The acute toxicity studies in mice models revealed that these analogues possess low systemic toxicity and are safe up to 1600mg/Kg. Among the compounds synthesized, 5-(2-nitrobenzylidene)-2-(isatin-3- azino)-thiazolidin-4-one (CI) has been shown to be the most active, highly promising compound which induced S phase arrest in cell cycle in a time dependent manner. Our initial analysis indicate that incorporation of electron withdrawing group at ortho position of the ring favors over the meta and para positions for eliciting its cytostatic effect. Overall, the in vitro biological evaluation suggests that the growth inhibitory effect of CI is promising and can be studied further.
Keywords: Isatin, thiazolidinone, cancer, cytotoxicity, cell cycle arrest, Isatin-Thiazolidinone Hybrid, Anti-Proliferative Agents, Phosphorylation, threonine, Alzheimer's, anti-proliferative effects, tyrosine kinases, p-glycoprotein, mitochondria, spectrophotometer, tetramethylsilane (TMS), DMEM, DMSO, 3-Thiosemicarbazone, 5-(2-Nitrobenzylidene), 4-Fluorobenzylidene, 4-Hydroxybenzylidene, isopropyl alcohol, ELISA microplate reader, cyclocondensation, NCI ADR Res, benzylidene ring, pharmacological screening, Trivandrum
Medicinal Chemistry
Title: Synthesis and In Vitro Evaluation of Some Isatin-Thiazolidinone Hybrid Analogues as Anti-Proliferative Agents
Volume: 6 Issue: 5
Author(s): P. K. Ramshid, Sankar Jagadeeshan, Anand Krishnan, Mary Mathew, S. Asha Nair and M. Radhakrishna Pillai
Affiliation:
Keywords: Isatin, thiazolidinone, cancer, cytotoxicity, cell cycle arrest, Isatin-Thiazolidinone Hybrid, Anti-Proliferative Agents, Phosphorylation, threonine, Alzheimer's, anti-proliferative effects, tyrosine kinases, p-glycoprotein, mitochondria, spectrophotometer, tetramethylsilane (TMS), DMEM, DMSO, 3-Thiosemicarbazone, 5-(2-Nitrobenzylidene), 4-Fluorobenzylidene, 4-Hydroxybenzylidene, isopropyl alcohol, ELISA microplate reader, cyclocondensation, NCI ADR Res, benzylidene ring, pharmacological screening, Trivandrum
Abstract: A range of isatin-thiazolidinone hybrid analogues were synthesized and their cytotoxicity was evaluated against several cancer cell lines in vitro. The acute toxicity studies in mice models revealed that these analogues possess low systemic toxicity and are safe up to 1600mg/Kg. Among the compounds synthesized, 5-(2-nitrobenzylidene)-2-(isatin-3- azino)-thiazolidin-4-one (CI) has been shown to be the most active, highly promising compound which induced S phase arrest in cell cycle in a time dependent manner. Our initial analysis indicate that incorporation of electron withdrawing group at ortho position of the ring favors over the meta and para positions for eliciting its cytostatic effect. Overall, the in vitro biological evaluation suggests that the growth inhibitory effect of CI is promising and can be studied further.
Export Options
About this article
Cite this article as:
K. Ramshid P., Jagadeeshan Sankar, Krishnan Anand, Mathew Mary, Asha Nair S. and Radhakrishna Pillai M., Synthesis and In Vitro Evaluation of Some Isatin-Thiazolidinone Hybrid Analogues as Anti-Proliferative Agents, Medicinal Chemistry 2010; 6 (5) . https://dx.doi.org/10.2174/157340610793358909
DOI https://dx.doi.org/10.2174/157340610793358909 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan as Drivers of Oncogenesis and Potential Drug Targets
Current Cancer Drug Targets ZIP4 is a Novel Diagnostic and Prognostic Marker in Human Pancreatic Cancer: A Systemic Comparison Between EUS-FNA and Surgical Specimens
Current Molecular Medicine Induction of Apoptosis in Macrophages via Kv1.3 and Kv1.5 Potassium Channels
Current Medicinal Chemistry Inhibitors for Metastasis Development
Recent Patents on Anti-Cancer Drug Discovery Patent Selections :
Recent Patents on CNS Drug Discovery (Discontinued) Blockade of Furin Activity and Furin-Induced Tumor Cells Malignant Phenotypes By The Chemically Synthesized Human Furin Prodomain
Current Medicinal Chemistry Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Current Genomics Analytical Approaches for Assaying Metallodrugs in Biological Samples: Recent Methodological Developments and Future Trends
Current Drug Metabolism Recent Advances in the Medicinal Chemistry of Phenothiazines, New Anticancer and Antiprotozoal Agents
Current Medicinal Chemistry Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment
Current Cancer Therapy Reviews Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Perspectives of Plant Natural Products in Inhibition of Cancer Invasion and Metastasis by Regulating Multiple Signaling Pathways
Current Medicinal Chemistry Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies
Clinical Cancer Drugs Novel Gastrin Receptor-Directed Contrast Agents - Potential in Brain Tumor Magnetic Resonance Imaging
Medicinal Chemistry Recent Advances in Targeting Nuclear Molecular Imaging Driven by Tetrazine Bioorthogonal Chemistry
Current Medicinal Chemistry 4-Aminocyclopentane-1,3-diols as Platforms for Diversity: Synthesis of Anandamide Analogs
Medicinal Chemistry MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies
Current Medicinal Chemistry Potential MicroRNA Targets for Cancer Chemotherapy
Current Medicinal Chemistry Targeting Cell Death in Tumors by Activating Caspases
Current Cancer Drug Targets Identification of Disease States and Response to Therapy in Humans by Utilizing the Biomarker EGFR for Targeted Molecular Imaging
Current Protein & Peptide Science